Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation
<p>Abstract</p> <p>Background</p> <p>Type 2 diabetes mellitus (T2DM) is commonly associated with both microvascular and macrovascular complications and a strong correlation exists between glycaemic control and the incidence and progression of vascular complications. Pio...
Main Authors: | Iuliano Luigi, De Angelis Giulia, Rizzo Paola, Pecorini Giovanni, Stigliano Egidio, Arena Vincenzo, Straface Giuseppe, Biscetti Federico, Ghirlanda Giovanni, Flex Andrea |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/8/1/49 |
Similar Items
-
Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity
by: Vincent Jacques, et al.
Published: (2021-08-01) -
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
by: Swanson Christine R, et al.
Published: (2011-08-01) -
Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
by: Nordsletten Lars, et al.
Published: (2009-03-01) -
PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling
by: Nasim Dana, et al.
Published: (2019-09-01) -
The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization.
by: Young Seok Park, et al.
Published: (2012-01-01)